This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages without signing in

Acute uveitis

Authoring team

Acute anterior uveitis associated with ankylosing spondylitis is one of the main causes of uveitis in the UK and USA (1).

Characteristically, acute anterior uveitis presents with:

  • pain
  • photophobia
  • redness
  • lacrimation

Examination of the eye shows redness all around the limbus (i.e. ciliary injection). The hyperaemia is followed by an exudation of protein and leukocytes into the anterior chamber; this gives rise to an "aqueous flare" as light is reflected back from the protein and cellular elements - analagous to the manner in which dust in the air shows in shafts of sunlight. The exudate may precipitate on the posterior surface of the cornea as keratic precipitates (KP's). Vision is blurred.

In advanced disease there may be:

  • inflammatory irritation of the pupil resulting in miosis
  • adhesions of the iris to the anterior surface of the lens (posterior synechiae)
  • administration of a mydriatic may result in irregular dilatation of the pupil

In Behcet's disease, acute anterior uveitis often presents with a hypopyon in one eye. The disease recurs and affects both eyes, resulting eventually, in blindness.

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.